Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures. Kuo JH, Ou YC, Hu CY, Wu KY, et al. Anticancer Res 2025;45:5709-5720.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kuo JH, Ou YC, Hu CY, Wu KY, et al. Optimizing Biopsy Decisions in PI-RADS 3-4 Lesions: Integrating PSA-derived Biomarkers to Reduce Unnecessary Procedures. Anticancer Res 2025;45:5709-5720.
PMID: 41318146